Health insurer United Health and Amedisys had been in talks for a $3.3 billion merger. In November, the Justice Department filed an antitrust lawsuit to block that merger. Amedisys' expected ...

Amedisys Stock Up 0.2 % Shares of Amedisys stock opened at $92.80 on Friday. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a ...

UnitedHealth Group and Amedisys have pushed back the closure date for their $3.3 billion merger as they fend off a federal challenge to the deal. Home health company Amedisys wrote in a filing ...

Amedisys has quashed a deal to sell more than 100 home health centers to a Dallas-based company. The Baton Rouge-based company announced the termination of the deal with VitalCaring late Wednesday.

BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Three-Month ...

UnitedHealth UNH-0.06%decrease; red down pointing triangle Group and Amedisys AMED-0.13%decrease; red down pointing triangle have terminated their deal to sell medical centers to VitalCaring Group ...

UnitedHealth Group has filed for more time to complete a $3.3 billion deal to buy Amedisys, a home health care and hospice company, after the companies agreed to waive deadlines in the face of ...

On Monday, shares of Amedisys (NASDAQ:AMED), a healthcare company with a market capitalization of $2.95 billion, remained steady following the announcement of an extension to its merger agreement with ...

Amedisys, Inc. filed a Form 8-K with the Securities and Exchange Commission (SEC) on January 3, 2025, announcing the termination of a purchase agreement. The agreement, initially entered into on ...

Below we provide more detail on these developments, among other notable M&A events that occurred during the final quarter of 2024. Please see full publication below for more information.

On Monday, RBC Capital Markets sustained their positive outlook on Amedisys (NASDAQ:AMED) shares, maintaining an Outperform rating and a $100.00 price target. The affirmation follows recent ...